Project Grant R03OD039969

Award Date 6/10/25
Completion Date 5/31/26
Dollars Obligated $1
Federal Grant Program
93.121
Assistance Type
Project Grant
Place of Performance
Colorado, USA
Similar Awards
This Project Grant award under the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $854,736 to Weill Medical College of Cornell University to develop advanced statistical methods for analyzing longitudinal microbiome studies. The key products and services to be delivered include: Approaches for addressing batch effects in large-scale longitudinal microbiome data Improved statistical models for identifying...
This $2,279,811 Project Grant, awarded by the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310), aims to transform the functional characterization of the gut microbiome. The grant supports the development of novel activity-based probes (ABPs) to directly measure enzymatic function and microbial mechanisms within the complex gut microbiome. The research will utilize both gnotobiotic mouse models and longitudinal cohorts of...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) will provide $516,648 over the period of Aug 28, 2024 to Feb 28, 2027 to The Leland Stanford Junior University to conduct research on understanding the mechanisms by which microbially-derived metabolites regulate host gut inflammation. The key products/services to be delivered under this award...
The National Science Foundation's Division of Integrative Organismal Systems awarded a $1,012,111 Project Grant to The Ohio State University to conduct research using machine learning and animal models to identify bacterial species and sub-networks within complex gut microbiomes that are essential for healthy animal development and growth. This interdisciplinary project leverages molecular and microbiological approaches, as well as legacy and cutting-edge machine learning tools, to analyze...
This Project Grant award, valued at $133,246, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The funding will support the development of flexible Bayesian statistical methods to gain a comprehensive understanding of microbial community dynamics using high-throughput sequencing data. The key objectives are to create a general method for inferring microbial community dynamics that vary with...
This Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) provides $426,425 to Baylor College of Medicine to conduct a pilot study examining the relationship between gut microbiome composition, metabolic dysfunction-associated steatotic liver disease (MASLD), and hepatocellular carcinoma (HCC). The key objectives of this 2-year study are to: 1) characterize baseline gut microbiome diversity associated with MASLD with and without HCC, 2)...
The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $548,949 Project Grant (CFDA 93.286: Discovery and Applied Research for Technological Innovations to Improve Human Health) to the University of California, San Diego (UCSD) to develop a novel diagnostic technique for accurately profiling the gut microbiome. The project aims to create a "living biosensor" that can record extracellular DNA as it traverses the intestinal tract, preserving information about...
This $325,139 federal Project Grant award, funded by the National Center for Advancing Translational Sciences (NCATS), 93.350 program, aims to examine the feasibility of using target-specific polyclonal antibodies to neutralize bioactive molecules in the gut microbiome. The primary goals are to 1) determine the impact of six proteins identified as overabundant in inflammatory gut disorders, and 2) evaluate the ability of immunoglobulin Y (IgY) antibodies to neutralize the physiological impacts...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) provides $1,928,697 to investigate the quantitative mechanisms by which the gut microbiome impacts human energy balance. The primary awardee, Adventist Health System / Sunbelt Inc. (doing business as AdventHealth Orlando), will conduct a randomized controlled crossover feeding study to...
This $462,000 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to investigate how the human microbiome regulates neutrophil immune responses and impacts sepsis outcomes. The key objectives are to: Elucidate the mechanism by which the microbiome "primes" or trains human neutrophils during homeostasis, leading to differential inflammatory responses....

CO-INFORMED PREDICTION OF MICROBIOME-METABOLOME INTERACTIONS THROUGH NOVEL TRANSFER LEARNING MODELS - ABSTRACT THE GUT MICROBIOME PLAYS A CRITICAL ROLE IN THE PATHOGENESIS OF HUMAN DISEASES THROUGH THEIR METABOLITES, ACTING AS A DYNAMIC INTERFACE BETWEEN OUR ENVIRONMENT AND HEALTH. RECENT PAIRED MICROBIOME-METABOLOME STUDIES ENABLE THE SIMULTANEOUS ANALYSIS OF HUNDREDS OF MICROBES AND METABOLITES, UNCOVERING THEIR ASSOCIA- TIONS WITH VARIOUS CONDITIONS IN UNPRECEDENTED DETAIL. INTEGRATIVE ANALYSES OF PAIRED MICROBIOME-METABOLOME DATA SETS REQUIRE MULTIVARIATE MODELS THAT CAN ACCOUNT FOR COMPLEX CORRELATION STRUCTURES BETWEEN MICROBES AND METABOLITES. HOWEVER, THESE MULTIVARIATE MODELS FACE THE CHALLENGE OF LOW STATISTICAL POWER FOR DETECTING MICROBIOME-METABOLOME INTERACTIONS DUE TO SMALL SAMPLE SIZES AND WEAK BIOLOGICAL SIGNALS. THEREFORE, THE OVERARCHING GOAL OF THE PROPOSED RESEARCH IS TO DEVELOP NOVEL STATISTICAL METHODS FOR THE POWERFUL DETECTION OF WEAK MICROBIOME-METABOLOME INTERACTIONS WITH LIMITED DATA. IN AIM 1, WE WILL DEVELOP A POWERFUL TRANSFER- LEARNING FRAMEWORK FOR HIGH-DIMENSIONAL REGRESSION MODELS WITH COMPOSITION COVARIATES. UNLIKE MOST EXISTING TRANSFER-LEARNING METHODS THAT BORROW INFORMATION FROM EXTERNAL DATA SETS, OUR FRAMEWORK LEVERAGES THE SIMI- LARITIES ACROSS METABOLITES WITHIN A SINGLE COHORT. THIS WILL HELP MINIMIZE THE POTENTIAL RISK OF NEGATIVE TRANSFER, GIVEN THE DIFFERENT SEQUENCING PLATFORMS AND BIOINFORMATIC PIPELINES USED IN DIFFERENT STUDIES. IN AIM 2, WE APPLY OUR TRANSFER-LEARNING METHOD TO THE HUMAN MICROBIOME PROJECT (HMP), THE INTEGRATIVE HUMAN MICROBIOME PROJECT (IHMP), AND AN EXTERNAL PAIRED MICROBIOME-METABOLOME DATA SET. OUR ANALYSES WILL REVEAL BIOLOGICALLY RELEVANT MICROBIOME-METABOLOME INTERACTIONS FOR BOTH HEALTHY PEOPLE AND PATIENTS DIAGONOSED WITH INFLAMMATORY BOWEL DISEASE (IBD), ADVANCING OUR UNDERSTANDING OF THE MICROBIOME-IBD LINK. FURTHERMORE, WE WILL ANALYZE BIOPSY- SPECIFIC MICROBIOME-METABOLOME INTERACTIONS FOR IBD PATIENTS, REVEALING POTENTIAL SPATIAL HETEROGENEITY FOR IBD- ASSOCIATED MICROBIOME AND METABOLITES. THIS PROPOSED RESEARCH IS DISTINGUISHED BY ITS ORIGINALITY IN INTRODUCING NOVEL, POWERFUL, AND FLEXIBLE TRANSFER-LEARNING FRAMEWORKS AND NOVEL APPLICATIONS OF MICROBIOME-METABOLOME INTERACTIONS IN BOTH HEALTHY AND IBD POPULATIONS.

Posted 6/10/25, 12:00 AM